Pulmonary Hypertension in Heart Failure

Pulmonary hypertension frequently complicates heart failure, increasing morbidity and mortality. Early recognition and targeted therapy are essential.

Key Highlights:

  • Pathophysiology: Increased pulmonary vascular resistance secondary to left heart disease.
  • Symptoms: Dyspnea, fatigue, and exercise intolerance.
  • Diagnosis: Echocardiography, right heart catheterization, and biomarkers.
  • Treatment: Vasodilators, diuretics, oxygen therapy, and management of underlying heart failure.
  • Prognosis: Early detection and treatment improve functional capacity and survival.

Addressing pulmonary hypertension in heart failure requires a multidisciplinary approach to optimize outcomes and reduce complications.

    Related Conference of Pulmonary Hypertension in Heart Failure

    October 06-07, 2025

    6th International Conference on Physics

    Paris, France
    December 01-02, 2025

    9th International Meeting on Fluid Dynamics & Fluid Mechanics

    Vancouver, Canada
    December 15-16, 2025

    13th World Congress on Physical and Theoretical Chemistry

    Amsterdam, Netherlands
    February 09-10, 2026

    9th World Congress On Cardiology and Heart Failure

    London, UK
    February 19-20, 2026

    4th World Congress on Quantum Physics

    Paris, France

    Pulmonary Hypertension in Heart Failure Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in